Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index; 24 of the 53 sources its claims cite were checked for support.

Systematic review of cost effectiveness and budget impact of artificial intelligence in healthcare

Open access
El Arab, Rabie Adel, Al Moosa, Omayma Abdulaziz · 2025 · npj Digital Medicine

Abstract

This systematic review examines 19 studies of clinical AI interventions across multiple specialties and finds economic promise, while warning that cost components are often underreported.

Overview

CoChat Summary

## TL;DR

This systematic review of 19 studies found that clinical AI interventions were generally associated with improved diagnostic accuracy, gains in QALYs, and frequent cost savings or favorable ICERs across multiple specialties. The authors caution that many studies used static models and omitted important cost components, so the reported economic value of AI may be overstated.

## Key findings

  • The review included 19 studies published from 2020 to 2024 across oncology, atrial fibrillation screening, gastrointestinal endoscopy, diabetic retinopathy screening, dental caries detection, ICU management, medication management, tuberculosis screening/monitoring, glaucoma screening, lung cancer screening, and breast cancer screening.
  • Economic evaluation types were CEA (n = 14), CUA (n = 4), CMA (n = 2), and BIA (n = 1); 13 studies used a healthcare system perspective, 4 a societal perspective, and 1 a payer perspective.
  • Example results reported in the paper include AF screening ICERs of £4847–£5544 per QALY gained, diabetic retinopathy screening cost reductions of 14–19.5% with ICERs as low as $1107.63 per QALY, and AI-assisted colonoscopy savings of $149.2 million in Japan and $85.2 million in the United States annually.
  • Reporting quality was high: CHEERS 2022 scores ranged from 21/28 to 27/28, and Drummond scores ranged from 8/10 to 9/10.

## Methods

  • The authors conducted a PRISMA 2020 systematic review of clinical AI economic evaluations, searching PubMed/MEDLINE, Embase, Web of Science, and the Cochrane Library from database inception to January 2025.
  • They screened 312 unique records, assessed 50 full-text articles, and included 19 studies after excluding studies for unclear/insufficient economic reporting, ineligible design, or no economic outcomes.
  • They extracted study characteristics and economic outcomes using a standardized form, then performed a thematic synthesis and quality appraisal with CHEERS 2022 and the Drummond checklist.

## Limitations

  • The paper states that many studies omitted indirect costs, upfront infrastructure costs, integration costs, and ongoing maintenance costs, which may overstate economic benefits.
  • The paper states that many evaluations used static decision-analytic models and did not capture adaptive learning or time-dependent performance improvements in AI; this may overestimate cost-effectiveness.
  • The paper states that equity was underexplored, with limited subgroup analyses and limited disaggregation by demographic variables.
  • Evident from the text: the review synthesized heterogeneous studies across settings, specialties, and methods, which the authors say may limit generalizability.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41746-025-01722-y

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 PRISMA 2020 flow diagram. This diagram illustrates the systematic review process, detailing each stage—from record identification through screening, eligibility assessment, and final inclusion—with explicit reasons for exclusion at various stages in accordance with the PRISMA 2020 guidelines.
Fig. 1 PRISMA 2020 flow diagram. This diagram illustrates the systematic review process, detailing each stage—from record identification through screening, eligibility assessment, and final inclusion—with explicit reasons for exclusion at various stages in accordance with the PRISMA 2020 guidelines.CC BY · PubMed Central

Verification

Claims the paper makes

21 Valid · 2 Not valid · 17 Not checked · 76 Own results and interpretations

64 more claims · 3 with their cited sources checked

Create a free account to see all 116 claims and to verify the 10 references still open.

See all claims — free account
  • It may state two separate claims as one. 29
  • Probably not a substantial claim. 18

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Self-check results appear here once an independent check has confirmed them.

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

1 of 1

Citations

Cites

1 retracted

Show all 58 references

Research works printed but not linked: 1

  1. Drummond, M. F., Sculpher, M. J., Claxton, K., Stoddart, G. L. & Torrance, G. W. Methods for the Economic Evaluation of Health Care Programmes. Consumption Benefits of Healthcare (Oxford University Press, London, 2015).

Cited by

See all 149

Metadata

Authors
El Arab, R. A., & Al Moosa, O. A.
Venue
npj Digital Medicine
Published
2025-08-26
Volume
8
Issue
1
Pages
548-548
ISSN
2398-6352 (ISSN-L)
OpenAlex
W4413645249
Cited by
149
References
58
Citations by year
2026: 123 · 2025: 25
FWCI
8.74
Type
journal article
Language
en
Open access
Licence
Locations
  • npj Digital Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Almoosa College of Health Sciences
Topics
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
Keywords
clinical AI, cost-effectiveness, budget impact, incremental cost-effectiveness ratio, diagnostic accuracy, quality-adjusted life years, health equity, ophthalmology, infectious diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Systematic review of cost effectiveness and budget impact of artificial intelligence in healthcare. https://app.cochat.ai/papers/10.1038/s41746-025-01722-y
The paper
El Arab, R. A., & Al Moosa, O. A. (2025). Systematic review of cost effectiveness and budget impact of artificial intelligence in healthcare. npj Digital Medicine. https://doi.org/10.1038/s41746-025-01722-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.